Prescription drug · ANDA
Rhuzdah NDC 59651-740
norethindrone and ethinyl estradiol tablet · Kit · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59651-740-88 | 5965107408859651074088 | 3 POUCH in 1 CARTON (59651-740-88) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACKMarketed from Oct 11, 2022 | |
| 59651-740-92 | 5965107409259651074092 | 6 POUCH in 1 CARTON (59651-740-92) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACKMarketed from Oct 11, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rhuzdah
- Generic name (nonproprietary)
- norethindrone and ethinyl estradiol tablet
- Dosage form
- Kit
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 59651
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207585
- Marketing start
- Listing expires
- Identifiers
- Product ID 59651-740_450fc33f-0716-47fe-b810-f10f372ab98aSPL ID 450fc33f-0716-47fe-b810-f10f372ab98aSPL set ID dea10e78-0e7b-4404-9c3a-ed2447a1788bRxCUI 238015, 748797, 749736, 2624207
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N459651074088followed by a unit qualifier and the quantityPackage 59651-0740-88. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE 1 LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD Reproduced with permission of the Population Council from J. Trussell,…
Excerpt only. Read the full label for complete information.
About NDC 59651-740
- What is NDC 59651-740?
- 59651-740 is the product NDC for Rhuzdah kit, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Rhuzdah (Norethindrone and ethinyl estradiol tablet).
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Rhuzdah?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.